China Medical System Stock Current Valuation
| CHSYFDelisted Stock | USD 0.93 0.00 0.00% |
Valuation analysis of China Medical System helps investors to measure China Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that China Medical's price fluctuation is very steady at this time. Calculation of the real value of China Medical System is based on 3 months time horizon. Increasing China Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the China pink sheet is determined by what a typical buyer is willing to pay for full or partial control of China Medical System. Since China Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of China Pink Sheet. However, China Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.93 | Real 0.79 | Hype 0.93 | Naive 0.93 |
The real value of China Pink Sheet, also known as its intrinsic value, is the underlying worth of China Medical System Company, which is reflected in its stock price. It is based on China Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of China Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of China Medical System helps investors to forecast how China pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of China Medical more accurately as focusing exclusively on China Medical's fundamentals will not take into account other important factors: China Medical System Company Current Valuation Analysis
China Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current China Medical Current Valuation | 3.84 B |
Most of China Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China Medical System is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, China Medical System has a Current Valuation of 3.84 B. This is 73.26% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 76.89% higher than that of the company.
China Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of China Medical could also be used in its relative valuation, which is a method of valuing China Medical by comparing valuation metrics of similar companies.China Medical is currently under evaluation in current valuation category among its peers.
China Fundamentals
| Return On Equity | 0.24 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.36 % | |||
| Operating Margin | 0.37 % | |||
| Current Valuation | 3.84 B | |||
| Shares Outstanding | 2.45 B | |||
| Shares Owned By Insiders | 49.55 % | |||
| Shares Owned By Institutions | 19.25 % | |||
| Price To Earning | 8.10 X | |||
| Price To Book | 1.71 X | |||
| Price To Sales | 0.45 X | |||
| Revenue | 8.34 B | |||
| Gross Profit | 6.25 B | |||
| EBITDA | 3.48 B | |||
| Net Income | 3.02 B | |||
| Cash And Equivalents | 5.25 B | |||
| Cash Per Share | 2.14 X | |||
| Total Debt | 573.81 M | |||
| Debt To Equity | 0.13 % | |||
| Current Ratio | 3.16 X | |||
| Book Value Per Share | 5.64 X | |||
| Cash Flow From Operations | 2.49 B | |||
| Earnings Per Share | 0.19 X | |||
| Number Of Employees | 5.45 K | |||
| Beta | 0.82 | |||
| Market Capitalization | 4.19 B | |||
| Total Asset | 15.81 B | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.06 % | |||
| Net Asset | 15.81 B | |||
| Last Dividend Paid | 0.52 |
About China Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Medical System's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Medical System based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in China Pink Sheet
If you are still planning to invest in China Medical System check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Medical's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |